Arthritis & Rheumatology

Arthritis & Rheumatology is the journal of the American College of Rheumatology published by Wiley, founded in 1958 as Arthritis and Rheumatism and renamed in 2014, covering the rheumatic diseases, indexed in the Science Citation Index Expanded and Scopus, with a 2025 impact factor of 9.9Arthritis & Rheumatology 是美国风湿病学会的会刊，由 Wiley 出版，1958 年以 Arthritis and Rheumatism 之名创刊，2014 年更名，涵盖风湿性疾病，被科学引文索引扩展版与 Scopus 收录，2025 年影响因子为 9.9。

Scope

• Clinical and basic research on the rheumatic and musculoskeletal diseases发表风湿性与肌肉骨骼疾病的临床与基础研究。
• Inflammatory arthritides such as rheumatoid arthritis and spondyloarthritis涵盖类风湿关节炎、脊柱关节炎等炎症性关节病。
• Autoimmune connective tissue diseases and vasculitis涵盖自身免疫性结缔组织病与血管炎。
• Osteoarthritis, osteoporosis and metabolic bone disease涵盖骨关节炎、骨质疏松与代谢性骨病。
• Clinical trials, translational studies, imaging and therapeutics涵盖临床试验、转化研究、影像学与治疗学。

History

• The journal began in 1958 as Arthritis and Rheumatism, the official journal of the American Rheumatism Association该刊 1958 年以 Arthritis and Rheumatism 之名创刊，是美国风湿病协会的会刊。
• It was renamed Arthritis & Rheumatology in 2014该刊 2014 年更名为 Arthritis & Rheumatology。
• It is published by Wiley on behalf of the American College of Rheumatology, the successor of the American Rheumatism Association该刊由 Wiley 代表美国风湿病学会（美国风湿病协会的后继组织）出版。
• Its impact factor peaked above 15 in 2021 and stood at 9.9 in 2025其影响因子 2021 年曾超过 15，至 2025 年为 9.9。

Editors

• The editor-in-chief is S. Louis Bridges, Jr. of the Hospital for Special Surgery and Weill Cornell Medicine, whose term runs to 2030现任主编为特种外科医院与威尔康奈尔医学院的 S. Louis Bridges Jr.，任期至 2030 年。
• He succeeded Daniel H. Solomon, who edited the journal from 2020 to 2025他接替了 Daniel H. Solomon，后者自 2020 年至 2025 年任主编。
• An international editorial board represents rheumatology centres in several countries其编委会由多国风湿病学中心的学者组成。
• Submissions undergo peer review, and the journal is hybrid open access稿件经同行评审，该刊为混合开放获取。